ID   SNU-790
AC   CVCL_5093
SY   SNU790
DR   cancercelllines; CVCL_5093
DR   Cosmic; 1024886
DR   Cosmic; 1065285
DR   Cosmic; 1151968
DR   IARC_TP53; 24495
DR   KCLB; 00790
DR   Wikidata; Q54955267
RX   PubMed=17134824;
RX   PubMed=38225447;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 33 hours (PubMed=17134824).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17134824).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): KCLB=00790
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,10
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   FGA: 20,25
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
RX   PubMed=17134824; DOI=10.1016/j.mce.2006.10.017;
RA   Koh C.-S., Ku J.-L., Park S.-Y., Kim K.-H., Choi J.-S., Kim I.-J.,
RA   Park J.-H., Oh S.K., Chung J.-K., Lee J.-H., Kim W.-H., Kim C.W.,
RA   Cho B.Y., Park J.-G.;
RT   "Establishment and characterization of cell lines from three human
RT   thyroid carcinomas: responses to all-trans-retinoic acid and mutations
RT   in the BRAF gene.";
RL   Mol. Cell. Endocrinol. 264:118-127(2007).
//
RX   PubMed=38225447; DOI=10.1038/s41526-024-00346-y; PMCID=PMC10789769;
RA   Ahn J.-H., Park S., Hwang Y.M., Choi Y.S., Yi J.W.;
RT   "Morphologic and genomic changes of thyroid cancer cell lines exposed
RT   to conditions of simulated microgravity.";
RL   NPJ Microgravity 10:8.1-8.14(2024).
//